WallStSmart

Medtronic PLC (MDT)vsSTRATA Skin Sciences Inc (SSKN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 114438% more annual revenue ($35.48B vs $30.98M). MDT leads profitability with a 13.0% profit margin vs -35.1%. SSKN appears more attractively valued with a PEG of 0.03. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

SSKN

Hold

41

out of 100

Grade: D

Growth: 3.3Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$86.58

$62.24 premium

UndervaluedFair: $24.34Overvalued

Intrinsic value data unavailable for SSKN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

SSKN2 strengths · Avg: 10.0/10
PEG RatioValuation
0.0310/10

Growing faster than its price suggests

Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

SSKN4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.53M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-2.0%2/10

ROE of -2.0% — below average capital efficiency

Revenue GrowthGrowth
-21.2%2/10

Revenue declined 21.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : SSKN

The strongest argument for SSKN centers on PEG Ratio, Price/Book. PEG of 0.03 suggests the stock is reasonably priced for its growth.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : SSKN

The primary concerns for SSKN are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

MDT profiles as a value stock while SSKN is a turnaround play — different risk/reward profiles.

MDT carries more volatility with a beta of 0.73 — expect wider price swings.

MDT is growing revenue faster at 8.7% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

STRATA Skin Sciences Inc

HEALTHCARE · MEDICAL DEVICES · USA

STRATA Skin Sciences, Inc., a medical technology company, develops, markets and markets products for the treatment of dermatological conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company is headquartered in Horsham, Pennsylvania.

Want to dig deeper into these stocks?